Echocardiography of Heart Failure: How to Use it in Routine Clinical Practice?

2018 ◽  
pp. 24-24
Author(s):  
Satoshi Nakatani
2018 ◽  
Vol 36 (Supplement 1) ◽  
pp. e217
Author(s):  
J. Klimas ◽  
V. Nemcekova ◽  
Z. Kmecova ◽  
E. Malikova ◽  
J. Srankova ◽  
...  

2021 ◽  
Vol 27 (6) ◽  
pp. 41-46
Author(s):  
V. I. Tseluyko ◽  
A. O. Lukyanenko ◽  
L. M. Yakovleva

The aim – to provide сlinical and functional characteristics of patients with heart failure (HF) admitted to the cardiologic clinic Materials and methods. We studied 150 in-patient cards of the patients who were consecutively admitted to City Clinical Hospital N 8 between August 2018 and September 2019. 124 (80.6 %) patients who had the diagnosis of HF were selected for the future analysis.Results and discussion. Among the examined HF patients, 89 (71.8 %) had HF stage ІІА,18 (14.5 %) had stage IIB and 17 (13.7 %) had stage I. 23 (18,5 %) of patients had left ventricle ejection fraction (LVEF) below 40 %, 101 (81.5 %) had preserved LVEF. 73 (58.9 %) of examined patients with HF were male, 51 (41.1 %) were female. Women were elder then men and were more likely to have stage II arterial hypertension (AH) while men were more likely to have stage 3 AH. Most females had HF with preserved LVEF.Conclusions. Most patients with HF have preserved LVEF which can be the result of HF hyperdiagnistics in the situation of missing NT-proBNP assessment. In the group of patients with preserved LVEF HF 19.8 % of patients have EF of 40–49 % while 20.8 % have LVEF over 62 %. The most common comorbidity in patients with preserved LVEF HF was AH (88.1 %), coronary artery disease (77.2 %), atrial fibrillation (29.4 %).


2003 ◽  
Vol 2 (1) ◽  
pp. 131
Author(s):  
A ZAPHIRIOU ◽  
S ROBB ◽  
G MENDEZ ◽  
T MURRAYTHOMAS ◽  
S HARDMAN ◽  
...  

2011 ◽  
Vol 7 (3) ◽  
pp. 225
Author(s):  
Gianfranco Sinagra ◽  
Michele Moretti ◽  
Giancarlo Vitrella ◽  
Marco Merlo ◽  
Rossana Bussani ◽  
...  

In recent years, outstanding progress has been made in the diagnosis and treatment of cardiomyopathies. Genetics is emerging as a primary point in the diagnosis and management of these diseases. However, molecular genetic analyses are not yet included in routine clinical practice, mainly because of their elevated costs and execution time. A patient-based and patient-oriented clinical approach, coupled with new imaging techniques such as cardiac magnetic resonance, can be of great help in selecting patients for molecular genetic analysis and is crucial for a better characterisation of these diseases. This article will specifically address clinical, magnetic resonance and genetic aspects of the diagnosis and management of cardiomyopathies.


Sign in / Sign up

Export Citation Format

Share Document